Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance
Clinical trial NCT03579654 · UNKNOWN
Trial details
- NCT number
- NCT03579654
- Sponsor
- OncBioMune Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-28
- Primary completion
- 2021-02-28
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.